We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,406
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LADR
11876
Ladder Capital
LADR
$1.27B
$41.2K ﹤0.01%
4,019
+3,460
+619% +$37.4K
INZY
11877
PUT
DELISTED
Inozyme Pharma
INZY
$41.2K ﹤0.01%
9,800
-11,300
-54% -$57.5K
STKH
11878
Steakholder Foods
STKH
$2.13M
$41.1K ﹤0.01%
+39
New +$48.2K
BHAT
11879
DELISTED
Blue Hat Interactive Entertainment Technology
BHAT
$41K ﹤0.01%
6
-5
-45% -$32.8K
DMAC icon
11880
DiaMedica Therapeutics
DMAC
$360M
$40.9K ﹤0.01%
15,868
+7,956
+101% +$25.6K
SRTA
11881
PUT
Strata Critical Medical Inc
SRTA
$522M
$40.9K ﹤0.01%
15,800
-8,200
-34% -$28.8K
CRCT icon
11882
Cricut
CRCT
$1.21B
$40.9K ﹤0.01%
4,398
+2,572
+141% +$27.2K
WTBA icon
11883
CALL
West Bancorporation
WTBA
$508M
$40.8K ﹤0.01%
+2,500
New +$46.2K
UEIC icon
11884
PUT
Universal Electronics
UEIC
$67.9M
$40.7K ﹤0.01%
4,500
+900
+25% +$8.87K
REX icon
11885
CALL
REX American Resources
REX
$1.47B
$40.7K ﹤0.01%
2,000
-800
-29% -$15K
CD
11886
PUT
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
$40.7K ﹤0.01%
4,900
-23,900
-83% -$194K
NCRA icon
11887
Nocera
NCRA
$3.6M
$40.5K ﹤0.01%
+901
New +$42.8K
LQDT icon
11888
CALL
Liquidity Services
LQDT
$1.36B
$40.5K ﹤0.01%
2,300
+900
+64% +$15.7K
LQDT icon
11889
PUT
Liquidity Services
LQDT
$1.36B
$40.5K ﹤0.01%
2,300
-300
-12% -$5.23K
SCHX icon
11890
PUT
Schwab US Large- Cap ETF
SCHX
$74.9B
$40.5K ﹤0.01%
2,400
+1,200
+100% +$21.1K
TXMD icon
11891
PUT
TherapeuticsMD
TXMD
$24M
$40.5K ﹤0.01%
13,400
-11,300
-46% -$42.8K
AWP
11892
abrdn Global Premier Properties Fund
AWP
$366M
$40.5K ﹤0.01%
+3,705
New +$43.7K
CHAT icon
11893
PUT
Roundhill Generative AI & Technology ETF
CHAT
$1.96B
$40.4K ﹤0.01%
+1,500
New +$42.7K
SPI
11894
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$40.4K ﹤0.01%
50,851
+48,632
+2,192% +$55.5K
ELVA
11895
Electrovaya
ELVA
$394M
$40.3K ﹤0.01%
+14,242
New +$55.8K
ICCM icon
11896
IceCure Medical
ICCM
$10.3M
$40.3K ﹤0.01%
+2,421
New +$76.1K
CERS icon
11897
PUT
Cerus
CERS
$601M
$40.2K ﹤0.01%
24,800
+3,900
+19% +$8.11K
HNDL icon
11898
CALL
Strategy Shares Nasdaq 7HANDL Index ETF
HNDL
$638M
$40.1K ﹤0.01%
+2,100
New +$42.1K
CLDT
11899
Chatham Lodging
CLDT
$605M
$40K ﹤0.01%
4,184
-74,263
-95% -$708K
IWC icon
11900
PUT
iShares Micro-Cap ETF
IWC
$1.52B
$40K ﹤0.01%
400
-1,600
-80% -$173K

Similar funds

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.